Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Holding TSE:ARKG?
Track your performance easily
TSE:ARKG Price & Analysis
ARKG ETF Chart & Stats
Day’s Range― - ―
52-Week RangeC$10.00 - C$14.71
Previous CloseC$11.41
VolumeN/A
Average Volume (3M)N/A
AUM5.12M
NAV10.23
Expense Ratio0.96%
Holdings Count41
Beta1.80
Inception DateNov 14, 2022
Next Dividend Ex-DateN/A
Dividend YieldN/A
Shares OutstandingN/A
Standard Deviation0.12
10 Day Avg. Volume1,013
30 Day Avg. VolumeN/A
Alpha-0.02
BMO ARK Genomic Revolution Fund Trust Units A (ARKG) Fund Flow Chart
BMO ARK Genomic Revolution Fund Trust Units A (ARKG) 1 year Net Flows: C$3M
ARKG ETF News
PremiumCompany Announcements
Recursion Pharmaceuticals’ Strategic Acquisition and Leadership Changes
ARKG ETF FAQ
What was TSE:ARKG’s price range in the past 12 months?
TSE:ARKG lowest ETF price was C$10.00 and its highest was C$14.71 in the past 12 months.
What is the AUM of TSE:ARKG?
As of Nov 18, 2024 The AUM of TSE:ARKG is 5.12M.
Is TSE:ARKG overvalued?
According to Wall Street analysts TSE:ARKG’s price is currently Undervalued.
Does TSE:ARKG pay dividends?
TSE:ARKG does not currently pay dividends.
How many shares outstanding does TSE:ARKG have?
Currently, no data Available
Which hedge fund is a major shareholder of TSE:ARKG?
Currently, no hedge funds are holding shares in TSE:ARKG
ARKG ETF Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Learn more about TipRanks Smart Score
For ETFs, the calculations for the Smart Score, Analyst Consensus, Price Target, Blogger Sentiment, News Sentiment and Insider Transactions are based on the weighted average of the ETF's holdings and some additional factors. Hedge Fund Trend, Crowd Wisdom and Technicals are based on the actual ETF ticker.
Top 10 Holdings
Crispr Therapeutics
7.22%
Twist Bioscience
5.88%
Exact Sciences Corp
5.36%
Recursion Pharmaceuticals, Inc
5.31%
Beam Therapeutics, Inc.
4.31%
Schrodinger, Inc.
4.14%
Intellia Therapeutics Inc
3.95%
CareDx Inc
3.76%
Ginkgo Bioworks Holdings, Inc.
3.75%
Ionis Pharmaceuticals Inc.
3.69%
Total47.38%
ETF Description
BMO ARK Genomic Revolution Fund Trust Units A
The fund is an actively managed fund that targets companies involved in the genomics industry.